Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05992688

The Sweet Kids Study (Stevia on Weight and Energy Effect Over Time)

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Arkansas Children's Hospital Research Institute · Academic / Other
Sex
All
Age
8 Years – 12 Years
Healthy volunteers
Accepted

Summary

This is an 8 to14-week three-arm randomized controlled in children 8 to 12 years old. The main purpose of the study is to evaluate if stevia has benefits for weight control and metabolic function relative to caloric sweeteners, and whether it provides benefits in this regard similar to water.

Detailed description

Up to 150 children will be enrolled in the study to achieve a final sample of 90 completers (30 per group). The proposed study will be an 8 to 14-week, three-arm, randomized, controlled, blinded trial in children ages 8 to 12 years from the Central Arkansas region. Children will be randomized to consume one of three beverages: 1) sucrose-sweetened beverage, 2) stevia-sweetened beverage, or 3) calorie-free flavored water beverage. Participants with excessive weight (BMI percentile ≥85th and \<140 percent of the 95th percentile) will complete a 14-week intervention whereas normal-weight (BMI percentile \<85th) participants will complete an 8-week intervention in parallel.

Conditions

Interventions

TypeNameDescription
OTHERSucrose sweetened beverageChildren who habitually consume sugar (sucrose) - sweetened beverages who are randomized to this arm, will consume the study product for 8 to 14 weeks.
OTHERStevia sweetened beveragesChildren who habitually consume sugar (sucrose) - sweetened beverages who are randomized to this arm, will consume the study product for 8 to 14 weeks.
OTHERCalorie free flavored water beverageChildren who habitually consume sugar (sucrose) - sweetened beverages who are randomized to this arm, will consume the study product for 8 to 14 weeks.

Timeline

Start date
2023-09-19
Primary completion
2026-05-31
Completion
2026-11-30
First posted
2023-08-15
Last updated
2025-12-22

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05992688. Inclusion in this directory is not an endorsement.